Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03622359 · ClinicalTrials.gov registry record · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
A NA study of Diabetes Mellitus and Peripheral Artery Disease, sponsored by Nationwide Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 192
- Enrollment target
- 1
- Study location
NCT03622359 is a NA study of Diabetes Mellitus and Peripheral Artery Disease that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 192 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03622359, a NA study of Diabetes Mellitus and Peripheral Artery Disease, is actively recruiting participants, sponsored by Nationwide Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing lower extremity revascularization procedures. We hypothesize that radiotracer imaging of the lower extremities will provide a sensitive non-invasive imaging tool for quantifying regional abnormalities in skeletal muscle perfusion and evaluating responses to medical treatment.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST SPECT/CT perfusion imaging
- DIAGNOSTIC_TEST PET/CT perfusion imaging
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03622359
The ClinicalTrials.gov registry entry for NCT03622359 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (90% lower). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which SPECT/CT perfusion imaging is the first listed.
NCT03622359 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03622359 about?
NCT03622359 is a clinical study titled "Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease". The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing l...
What is the current status of trial NCT03622359?
This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2017-02-17. Estimated completion is 2028-12-31.
What conditions does trial NCT03622359 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Peripheral Artery Disease, Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT03622359?
The interventions under investigation include: SPECT/CT perfusion imaging (DIAGNOSTIC_TEST), PET/CT perfusion imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03622359?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03622359 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.